Institutes of Biomedical Research Corp (MRES)

[Lexit]

There's only ONE Patent and it's Canadian.

More half truths...sigh...

US Patent has been in limbo for years.

The WPO ID is : WO/1998/058076 -

It took over 10 years and a lot of corrections and amendements. The THE NEURO GROUP INC. (Canada) (not Neuro-Biotech Corp) was awarded a Canadian Patent on 13 April 2010 - ID: CA 2294179

http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2294179/summary.html#View_Images

The patent application was withdrawn in many other jurisdictions:

http://www.wipo.int/pctdb/en/fetch.jsp?SEARCH_IA=CA1998000533&DBSELECT=PCT&C=10&TOTAL=1&IDB=0&TYPE_FIELD=256&SERVER_TYPE=19-10&SORT=41301951-KEY&QUERY=(PA/Neuro-biotech)+&START=1&ELEMENT_SET=B&RESULT=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&IDOC=47655&IA=CA1998000533&LANG=ENG&DISPLAY=NATIONAL

In short, the patent agent went jurisdiction shopping and finally convinced one Patent authority to grant.

Explains why they were so concerned about the patent being on shaky ground in their 2000 SEC filing:

PATENTS AND PROPRIETARY INFORMATION

There has been, and the Company believes that there may be in the future, significant litigation in the industry regarding patent and other intellectual property rights and that, if the Company becomes involved in such litigation, it could consume substantial resources. Significant legal issues remain as to the extent to which patent protection may be afforded in the field of biotechnology in the United States, Canada and other countries, and the scope of any such protection has not yet been broadly tested. The Company, therefore, also relies upon trade secrets, know-how, and continuing technological advancement to
develop and maintain its competitive position.Disclosure and use of the Company's know-how is generally controlled under agreements with the parties involved. In addition, the Company has confidentiality agreements with its key employees, consultants, officers and directors. There can be no assurance,
however, that all confidentiality agreements will be honored, that others will not independently develop equivalent technology, that disputes will not arise as to the ownership of intellectual property, or that disclosure of the Company's trade secrets will not occur. Furthermore, there can be no assurance that others have not obtained or will not obtain patent protection that will exclude the Company from using its trade secrets and confidential information. To the extent that consultants or research collaborators use intellectual property owned by others in their work with the Company, disputes may also arise as to the rights to related or resulting know-how or inventions.


http://www.sec.gov/Archives/edgar/data/1120603/000091205700034121/0000912057-00-034121-index.htm

This is being sold as the greatest thing next to sliced bread. However, the simple truth is that this product has never made it to market in well over 10 years, it is not sold in any major drugstore chain anywhere in the world.